Evidence-graded

GLP-1 hair loss treatment: what works, and what doesn't

Most pages ranking for this sell you a supplement. Here is each option graded by the actual evidence — including the one that can distort emergency lab tests, and the case where the standard advice to “just wait” is wrong.

Verified Jul 2026 · re-checked quarterlyBy the GLP1Zoom editorial teamWe compare, we don’t sell

The short answer

The usual cause is telogen effluvium from rapid weight loss, which is self-limiting — it resolves in six to nine months(per the American Academy of Dermatology), so the “treatment” is support, not a drug: adequate protein, correcting a real iron deficiency, a steadier pace of loss. Biotin does not help and can mask a heart attack on lab tests. The real exception is pattern hair loss that the weight loss unmasked — that one does not self-resolve and needs minoxidil.

Key takeaways

Telogen effluvium is self-limiting — the AAD puts recovery at six to nine months after the trigger settles.
Biotin: no benefit without deficiency, and the FDA warns it skews lab tests including troponin. Avoid it.
Ferritin below 30 ng/mL is the conventional deficiency threshold; 50/70 are convention, not trial-proven.
Protein and a steadier pace of weight loss are sensible but not proven to treat shedding.
Minoxidil treats pattern hair loss, not telogen effluvium — but that is exactly the "it never grew back" case.
Stopping the drug regains most of the weight (≈two-thirds within a year) to fix shedding that usually self-resolves.

First, get the diagnosis right — it changes everything

Almost all GLP-1 hair shedding is telogen effluvium: rapid weight loss pushes a larger share of follicles into the resting phase, and they shed a few months later. It is diffuse (all over, not patchy), non-scarring, and self-limiting. But a meaningful minority of “my hair won't grow back” cases are something else — the weight loss unmasked pre-existing pattern hair loss (androgenetic alopecia) that was already developing. The two need opposite approaches: telogen effluvium you support and wait out; pattern loss you treat. Getting this wrong is why people spend months on supplements that were never going to help.

The treatments, graded

✓ Supported: correct a real deficiency (test first)

A single blood panel — ferritin, vitamin D, zinc, TSH, plus a CBC — tells you whether there is anything to correct. Deficiencies are less common in telogen effluvium than assumed, so testing beats blanket supplementing. On iron specifically: the conventional deficiency threshold is a ferritin below 30 ng/mL, and the study that found a real difference in shedding sat at below 15. The 50 and 70 ng/mL targets you see quoted are expert convention, not trial-derived. And because ferritin rises with obesity, a normal-looking number can still hide iron deficiency in exactly this population — so read it alongside the rest of the panel, not alone.

✓ Sensible, not proven: protein and a steadier pace

Low protein intake is a recognised telogen-effluvium trigger, and appetite drops so sharply on these drugs that under-eating protein is easy. Adequate protein is a reasonable step, though no trial has proven a specific target treats shedding. Likewise, since the trigger is the rate and amount of weight lost, a gentler pace is a plausible lever — but that too is inference, not tested. Neither will hurt, and both help muscle preservation regardless.

✗ Not supported, and potentially harmful: biotin

Biotin benefits hair only in people with a genuine deficiency, which is rare — and biotin levels are not even low in telogen-effluvium patients. More importantly, the FDA warns that biotin interferes with lab tests, including troponin, where it can produce a falsely low result and mask a heart attack, and it distorts thyroid and hormone panels too. It is the one popular “hair supplement” to actively avoid.

✗ Wrong tool for telogen effluvium — right tool for the unmasked case: minoxidil

Minoxidil is FDA-approved for pattern hair loss, not telogen effluvium, and studies find it neither shortens nor reverses telogen shedding. Using it for pure telogen effluvium is off-label and weakly supported, and it causes a paradoxical extra shed when you start — alarming if you do not expect it. But if a dermatologist finds that rapid weight loss unmasked pattern hair loss, minoxidil is the evidence-based treatment for that. This is the whole reason the diagnosis comes first.

Should you stop the medication?

For most people the trade does not favour stopping. The shedding is temporary and stops as weight stabilizes even while you continue — no Zepbound trial patient discontinued because of hair loss. Stopping the drug means regaining most of the weight: in the withdrawal trials, roughly two-thirds of semaglutide weight loss returned within a year, and tirzepatide regained about 14% over the year after stopping. That is a large, well-evidenced downside to trade against shedding that usually self-resolves. It is still your prescriber's call, but the numbers are worth bringing to that conversation.

When to see a dermatologist

Smooth round or oval bald patches — possible alopecia areata, a different condition.
A smooth shiny scalp with redness, scaling or scarring — possible scarring alopecia, which is urgent because scarring is irreversible.
A widening part or crown thinning — pattern hair loss, which needs its own treatment and will not self-resolve.
Shedding lasting beyond six to nine months, or paired with fatigue and cold intolerance (possible thyroid or iron problem).

For the mechanism, the label numbers and the full timeline, see does GLP-1 cause hair loss, or the per-drug pages for Ozempic, Wegovy, Zepbound and Mounjaro.

Common questions about GLP-1 hair loss treatment

What is the best treatment for GLP-1 hair loss?

For the usual cause — telogen effluvium from rapid weight loss — the honest answer is that it is self-limiting and resolves in six to nine months, so the "treatment" is supporting it rather than a drug: adequate protein, correcting a real iron deficiency, and a steadier pace of weight loss. The exception is when rapid weight loss has unmasked pre-existing pattern hair loss (androgenetic alopecia), which does not self-resolve and does have an evidence-based treatment: topical minoxidil.

Does biotin help GLP-1 hair loss?

No, unless you have a genuine biotin deficiency, which is rare. Every reported case of benefit involved an underlying deficiency, and biotin levels are not even low in telogen effluvium patients. The FDA also warns that biotin interferes with lab tests — including troponin, where it can produce a falsely low result and mask a heart attack. It is the one supplement to actively avoid.

What ferritin level causes hair loss?

The conventional deficiency threshold is a ferritin below 30 ng/mL, and a 2025 case-control study found the clear difference at below 15. Targets of 50 or 70 ng/mL that circulate online trace to expert convention, not a controlled trial. One caveat matters specifically on a GLP-1: ferritin is an acute-phase reactant and obesity raises it, so a normal-looking reading can still sit on top of real iron deficiency. Every one of these is an association — no trial shows iron supplements regrow hair in telogen effluvium.

Should I stop my GLP-1 to save my hair?

That is a conversation for your prescriber, but the trial data argues against it for most people: no Zepbound trial patient stopped treatment because of hair loss, the shedding is temporary, and it stops as weight stabilizes even if you continue. Stopping the medication means regaining most of the weight — in the withdrawal trials, roughly two-thirds of semaglutide weight loss returned within a year — which is a large trade for shedding that usually resolves on its own.

Does minoxidil work for GLP-1 hair loss?

It depends on the diagnosis. Minoxidil is FDA-approved for pattern hair loss (androgenetic alopecia), not telogen effluvium, and it is not an effective treatment for pure telogen effluvium. But if the real problem is pattern loss that rapid weight loss unmasked — the common reason hair "never comes back" — then minoxidil is the evidence-based option. This is exactly why getting the diagnosis right matters before treating.

References(7)

Our sourcing standards →

Wegovy (semaglutide) prescribing information — hair loss 3% vs 1%, Section 6.1NIH — FDA / DailyMed
Zepbound (tirzepatide) prescribing information — hair loss ~5% vs 1%, Section 6.1NIH — FDA / DailyMed
Hair loss and telogen effluvium — triggers include crash dieting and low protein intakeNCBI — StatPearls (NIH), 2024
Hair loss after metabolic and bariatric surgery — systematic review and meta-analysis (n=2,538)NCBI — Obesity Surgery, 2021